Pancreatic cancer screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Screening== | ==Screening== | ||
In the general population, screening of large groups is not currently considered effective, although newer techniques, and the screening of tightly targeted groups, are being evaluated.<ref name="He2014">{{cite journal | author = He XY, Yuan YZ | title = Advances in pancreatic cancer research: moving towards early detection | journal = World J. Gastroenterol. | volume = 20 | issue = 32 | pages = 11241–8 | date = August 2014 | pmid = 25170208 | pmc = 4145762 | doi = 10.3748/wjg.v20.i32.11241 }}</ref><ref name="Okano2014">{{cite journal | author = Okano K, Suzuki Y | title = Strategies for early detection of resectable pancreatic cancer | journal = World J. Gastroenterol. | volume = 20 | issue = 32 | pages = 11230–40 | date = August 2014 | pmid = 25170207 | pmc = 4145761 | doi = 10.3748/wjg.v20.i32.11230 }}</ref> Nevertheless, regular screening with endoscopic ultrasound and MRI/CT imaging is recommended for pancreatic cancer in high risk individuals. | *In the general population, screening of large groups is not currently considered effective, although newer techniques, and the screening of tightly targeted groups, are being evaluated.<ref name="He2014">{{cite journal | author = He XY, Yuan YZ | title = Advances in pancreatic cancer research: moving towards early detection | journal = World J. Gastroenterol. | volume = 20 | issue = 32 | pages = 11241–8 | date = August 2014 | pmid = 25170208 | pmc = 4145762 | doi = 10.3748/wjg.v20.i32.11241 }}</ref><ref name="Okano2014">{{cite journal | author = Okano K, Suzuki Y | title = Strategies for early detection of resectable pancreatic cancer | journal = World J. Gastroenterol. | volume = 20 | issue = 32 | pages = 11230–40 | date = August 2014 | pmid = 25170207 | pmc = 4145761 | doi = 10.3748/wjg.v20.i32.11230 }}</ref> Nevertheless, regular screening with endoscopic ultrasound and MRI/CT imaging is recommended for pancreatic cancer in high risk individuals. | ||
*Individuals with the following conditions are at an increased risk of pancreatic cancer:<ref name="pmid26320426">{{cite journal| author=Goral V| title=Pancreatic Cancer: Pathogenesis and Diagnosis. | journal=Asian Pac J Cancer Prev | year= 2015 | volume= 16 | issue= 14 | pages= 5619-24 | pmid=26320426 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26320426 }} </ref> | |||
**Hereditary pancreatitis | |||
**Familial pancreatic cancer | |||
**Peutz-Jeghers disease, | |||
**Familial atypical mole melanoma | |||
**Cystic fibrosis of pancreas, | |||
**Familial cancer syndromes such as: | |||
***Lynch syndrome | |||
***Familial adenomatous polyposis (FAP) | |||
***Hereditary breast and ovarian cancer-BRCA1 and BRCA2 mutations | |||
==References== | ==References== | ||
Revision as of 15:24, 15 November 2017
|
Pancreatic cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pancreatic cancer screening On the Web |
|
American Roentgen Ray Society Images of Pancreatic cancer screening |
|
Risk calculators and risk factors for Pancreatic cancer screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
In the general population, screening of large groups is not currently considered effective, although newer techniques, and the screening of tightly targeted groups, are being evaluated.[1][2] Nevertheless, regular screening with endoscopic ultrasound and MRI/CT imaging is recommended for pancreatic cancer in high risk individuals.
Screening
- In the general population, screening of large groups is not currently considered effective, although newer techniques, and the screening of tightly targeted groups, are being evaluated.[1][2] Nevertheless, regular screening with endoscopic ultrasound and MRI/CT imaging is recommended for pancreatic cancer in high risk individuals.
- Individuals with the following conditions are at an increased risk of pancreatic cancer:[3]
- Hereditary pancreatitis
- Familial pancreatic cancer
- Peutz-Jeghers disease,
- Familial atypical mole melanoma
- Cystic fibrosis of pancreas,
- Familial cancer syndromes such as:
- Lynch syndrome
- Familial adenomatous polyposis (FAP)
- Hereditary breast and ovarian cancer-BRCA1 and BRCA2 mutations
References
- ↑ 1.0 1.1 He XY, Yuan YZ (August 2014). "Advances in pancreatic cancer research: moving towards early detection". World J. Gastroenterol. 20 (32): 11241–8. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.
- ↑ 2.0 2.1 Okano K, Suzuki Y (August 2014). "Strategies for early detection of resectable pancreatic cancer". World J. Gastroenterol. 20 (32): 11230–40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.
- ↑ Goral V (2015). "Pancreatic Cancer: Pathogenesis and Diagnosis". Asian Pac J Cancer Prev. 16 (14): 5619–24. PMID 26320426.